Pharmacogenomics · 2009 · 17 citations · 78 references
MedicineDermatologyImmunologyImmunogeneticsImmunopathologyPharmacogeneticsAutoimmune Skin DiseasesDrug-induced Skin ReactionsHypersensitivity PharmacologyImmunopathology Of SkinInflammatory Skin DiseasesInflammatory Skin DisordersBullous Drug EruptionsDrug-induced Bullous DermatosisDrug-induced Skin EruptionsIdiosyncratic Adverse Drug ReactionsPharmacogenetic DisordersPharmacogenetic StudiesSevere Cutaneous Adverse ReactionsSkin Disease Genetics
The overall immunopathogenesis relevant to a large series of disorders caused by a drug or its associated hyperimmune condition is discussed based upon the examination of the genetics of severe drug-induced bullous skin problems (sporadic idiosyncratic adverse events, including Stevens-Johnson syndrome and toxic epidermal necrolysis). An overarching pharmacogenetic schema is proposed. Immune cognition and early-effector processes are focused upon and a challenging synthesis around systems evolution is explained by a variety of projective analogies. Etiology, human leukocyte antigen-B, immune stability, dysregulation, pharmacomimicry, viruses and an aggressive ethnically differentiated 'karmic' response are discussed.
78
HLA-B*5701 Screening for Hypersensitivity to Abacavir
S. Mallal, Elizabeth J. Phillips, Giampiero Carosi et al. · New England Journal of Medicine · 2008 · 1.8K citations · Full text
A marker for Stevens–Johnson syndrome
Wen‐Hung Chung, Hong‐Shang Hong, Mo‐Song Hsih et al. · Nature · 2004 · 1.7K citations